Community Series in Immunotherapy and Small Molecule Inhibitors as Combinational Cancer Therapeutics: Volume II

3,620
Total downloads
11k
Total views and downloads

Articles

SYSTEMATIC REVIEW

Published on 06 Dec 2024

Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials

Xinmiao Zhang
Jinhai Shen
Mengfan Huang
Rongxia Li

doi 10.3389/fimmu.2024.1507977

401 views

ORIGINAL RESEARCH

Published on 25 Nov 2024

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors and platinum-containing chemotherapy for later-line advanced non-small cell lung cancer: a retrospective three-arm real-world study using propensity-score matching

Zeyang Wang
Bingnan Ren
Haotian Yang
Xuejia Qiu
Yin Wu
Chaojun Xue
Yue Zhao
Xiao Li
Ze Yu
Jinyuan Zhang

doi 10.3389/fonc.2024.1446950

360 views

REVIEW

Published on 01 Nov 2024

Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium

Deeptashree Nandi
Dipali Sharma

doi 10.3389/fimmu.2024.1477980

455 views

ORIGINAL RESEARCH

Published on 24 Oct 2024

Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer

Qian Zhao
Lei Wang
Huilan Fu
Yuqin Zhang
Qiankun Xie

doi 10.3389/fimmu.2024.1467429

428 views

ORIGINAL RESEARCH

Published on 24 Oct 2024

Identification of beneficial populations for targeted-immunotherapy combinations: tailoring later-line care for patients with pMMR/MSS metastatic colorectal cancer

Dan Li
Hui Jin
Yan Liu
Jiayin Liu
Xue Zhang
Long Wang
Zhisong Fan
Li Feng
Jing Zuo
1 more
Yudong Wang

doi 10.3389/fimmu.2024.1462346

344 views

SYSTEMATIC REVIEW

Published on 16 Oct 2024

Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis

Sandeep Sisodiya
Vishakha Kasherwal
Jyoti Rani
Neetu Mishra
Sandeep Kumar
Asiya Khan
Mehreen Aftab
Shagufta
Payal Singh
2 more
Showket Hussain

doi 10.3389/fimmu.2024.1469441

875 views

SYSTEMATIC REVIEW

Published on 16 Sep 2024

Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis

Zhihong Zhao
Jian Ruan
Minjie Fang
Jingwen Liu
Guixiang Liao

doi 10.3389/fimmu.2024.1459693

751 views

SYSTEMATIC REVIEW

Published on 14 Aug 2024

Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis

Changhui Zhou
Weihua Wang
Ying Mu
Min Meng

doi 10.3389/fimmu.2024.1393404

671 views

REVIEW

Published on 09 Aug 2024

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

Tong Liu
Guorui Meng
Shihui Ma
Junqi You
Liang Yu
Risheng He
Xudong Zhao
Yunfu Cui

doi 10.3389/fimmu.2024.1455716

1,134 views

CASE REPORT

Published on 18 Jun 2024

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

Yanzhu Qin
Shuaiji Lu
Jingwen Chen
Jing Peng
Jijun Yang

doi 10.3389/fonc.2024.1415748

813 views
1 citation

MINI REVIEW

Published on 21 Feb 2024

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects

Xuefeng Wang
Yu Wang
Yonggang Zhang
Hongyun Shi
Kuan Liu
Fang Wang
Yue Wang
Huijing Chen
Yan Shi
Ruiyao Wang

doi 10.3389/fimmu.2024.1357101

1,297 views
2 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

11kTopic views
6,759Article views
3,620Article downloads

View impact

Submit your idea

Articles

Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors and platinum-containing chemotherapy for later-line advanced non-small cell lung cancer: a retrospective three-arm real-world study using propensity-score matching

Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium

Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer

Identification of beneficial populations for targeted-immunotherapy combinations: tailoring later-line care for patients with pMMR/MSS metastatic colorectal cancer

Impact of combinatorial immunotherapies in breast cancer: a systematic review and meta-analysis

Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis

Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects

Frontiers in Immunology

Participating Journals

Submit your idea

Impact